Last Price
0.327
Today's Change
+0.097 (42.35%)
Day's Change
0.306 - 0.466
Trading Volume
169,444,059
Market Cap
4 Million
Shares Outstanding
14 Million
Avg Volume
2,802,242
Avg Price (50 Days)
0.48
Avg Price (200 Days)
7.86
PE Ratio
-0.20
EPS
-1.64
Earnings Announcement
27-Nov-2024
Previous Close
0.23
Open
0.38
Day's Range
0.306 - 0.4658
Year Range
0.207 - 13.558
Trading Volume
169,453,845
1 Day Change
43.05%
5 Day Change
46.62%
1 Month Change
-11.11%
3 Month Change
-80.71%
6 Month Change
-97.12%
Ytd Change
-96.99%
1 Year Change
-96.98%
3 Year Change
-96.64%
5 Year Change
-96.72%
10 Year Change
-96.72%
Max Change
-96.72%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Silexion Therapeutics LTD, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. The company was founded in 2008 and is headquartered in Jerusalem, Israel.